This quartet of stocks has had a rough go of it in 2021 but could rebound in the coming year.
The shares have weakened significantly the past 12 months.
Small-cap biotech Marker Therapeutics and online appliance seller 1847 Goedeker have been beaten down lately but offer hope for bouncing back.
The technical signals are indicating that the stock of the Western apparel retailer may be running out of steam after a long run higher this year.
I think I'm likely to remain 'skinny' for now, and prioritize trading over investment at least for the next 10 business days or so.
Money-losing companies, even those who have potentially good prospects, are becoming less valuable on an absolute basis by the amount of their losses.
Omicron may not be as deadly as feared, but inflation, growth, technical conditions, and central bank uncertainties continue to pressure the market.
The spotlight is back on Evergrande after it filed a stock-exchange notice that it may not be able to keep up with its debt obligations.
Last week, we saw the complacency leave the market, and the bearishness finally creep in.
These names are displaying both quantitative and technical deterioration.